Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer
Lisanne Heim, Katerina Kachler, R. Siegmund, et al.
British Journal of Cancer (2019) Vol. 120, Iss. 9, pp. 903-912
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar, Yuliya Pylayeva‐Gupta
Cancers (2021) Vol. 13, Iss. 2, pp. 167-167
Open Access | Times Cited: 213
Therapeutic targeting of regulatory T cells in cancer
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 944-961
Open Access | Times Cited: 119
IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
Kewei Liu, Ai Huang, Jun Nie, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
CAR T Cell Locomotion in Solid Tumor Microenvironment
Duy Nguyen, Elizabeth Ogando‐Rivas, Ruixuan Liu, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1974-1974
Open Access | Times Cited: 32
Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker
Xi Yan, Lina Han, Riyang Zhao, et al.
Heliyon (2022) Vol. 8, Iss. 8, pp. e09953-e09953
Open Access | Times Cited: 22
IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer
Lisanne Heim, Zuqin Yang, Patrick Tausche, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Human interleukin-12α and EBI3 are cytokines with anti-inflammatory functions
Karen Hildenbrand, Sina Bohnacker, Priyanka Rajeev Menon, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 13
The possible anti-tumor effects of regulatory T cells plasticity / IL-35 in the tumor microenvironment of the major three cancer types
Rehab G. Khalil, Dina Mostafa Mohammed, Hadeer M. Hamdalla, et al.
Cytokine (2024) Vol. 186, pp. 156834-156834
Closed Access | Times Cited: 3
IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment
Pengcheng Yi, Wenjun Yu, Yanhong Xiong, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 2, pp. 148-158
Closed Access | Times Cited: 9
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Jialin Zhu, Yan Wang, Li Dai, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 19
IL-35 promotes EMT through STAT3 activation and induces MET by promoting M2 macrophage polarization in HCC
Yuan He, Jinhong Pei, Xueqing Li, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 559, pp. 35-41
Closed Access | Times Cited: 16
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study
Yuki Katayama, Tadaaki Yamada, Kenji Morimoto, et al.
JTO Clinical and Research Reports (2023) Vol. 4, Iss. 4, pp. 100494-100494
Open Access | Times Cited: 6
Flow Cytometry: From Experimental Design to Its Application in the Diagnosis and Monitoring of Respiratory Diseases
Julio Flores‐González, Juan C. Cancino‐Díaz, Leslie Chávez‐Galán
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8830-8830
Open Access | Times Cited: 12
Interleukin-35 expression promotes hepatocellular carcinogenesis by inducing γδ T-cell exhaustion
He Ren, Xin Liu, Qiao Xu, et al.
Genomics (2023) Vol. 115, Iss. 3, pp. 110639-110639
Open Access | Times Cited: 4
The Role of IL-35 in the Pathophysiological Processes of Liver Disease
Shuang Hu, Panpan Lian, Ying Hu, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 10
HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization
Stanley Borowicz, Daniel R. Principe, Matthew J. Dorman, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252197-e0252197
Open Access | Times Cited: 8
The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
Yuqiu Hao, Hongna Dong, Wěi Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis
Qinglai Jiang, Yuxuan Li, Liping Xia, et al.
Journal of Interferon & Cytokine Research (2019) Vol. 39, Iss. 11, pp. 720-725
Closed Access | Times Cited: 6
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
Yuto Terashima, Masaru Matsumoto, Hiroki Iida, et al.
JTO Clinical and Research Reports (2023) Vol. 4, Iss. 11, pp. 100578-100578
Open Access | Times Cited: 2
Effect of Sintilimab combined with Chemotherapy on Tumor Markers and Immune Function of advanced non-small cell lung cancer
Xiaoyan Liang, Zhangfeng Wei
Pakistan Journal of Medical Sciences (2021) Vol. 37, Iss. 4
Open Access | Times Cited: 5
Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features
Nathalie Bendriss‐Vermare, Valentin Picant, Lara Revol-Bauz, et al.
Research Square (Research Square) (2024)
Open Access
Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study
Maha Fathy Elmasry, Yasmine Ahmed Obaid, Solwan Ibrahim El-Samanoudy, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Open Access
Tislelizumab synergizes with surgery to augment the survival benefit in stage II-III non-small cell lung cancer
Xuhua Huang, Linhai Zhu, Jia-Cong Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Tumor immunology
Pouya Mahdavi Sharif, Amin Pastaki Khoshbin, Elaheh Nasrollahzadeh, et al.
Elsevier eBooks (2023), pp. 245-452
Closed Access | Times Cited: 1
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
Irene Olivera, Carlos Luri‐Rey, Álvaro Teijeira, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4711-4727
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top